Endoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Gastric Cancer. 2012 Apr;15(2):221-5. doi: 10.1007/s10120-011-0111-8. Epub 2011 Nov 15.
Currently in Japan, differentiated gastric submucosal invasive cancers <500 μm (SM1) with negative lymphovascular involvement are included in expanded pathological criteria for curative endoscopic treatment. This is based on a retrospective examination of surgical resection cases in which patients suitable for such expanded criteria were determined to have a negligible risk of lymph node metastasis. We performed endoscopic submucosal dissection on a 65-year-old male with early gastric cancer in April 2005, and pathology revealed a well-differentiated adenocarcinoma, 21 × 10 mm in size, SM1 invasion depth and negative lymphovascular invasion as well as tumor-free margins, so the case was diagnosed as a curative resection. This case, however, resulted in lymph node metastasis that was diagnosed by endoscopic ultrasonography with fine-needle aspiration biopsy in May 2009. Distal gastrectomy with D2 lymph node dissection was then performed, confirming lymph node metastasis from the original gastric cancer.
目前在日本,对于浸润深度达黏膜下层 500μm 以内(SM1)且无淋巴管及血管侵犯的分化型胃黏膜下浸润癌,被纳入扩大内镜治疗的适应证。这是基于对手术切除病例的回顾性研究,对于符合这些扩大适应证的患者,判断其淋巴结转移风险可忽略不计。我们于 2005 年 4 月对一名 65 岁男性的早期胃癌患者实施了内镜黏膜下剥离术,术后病理示分化型腺癌,大小为 21×10mm,浸润至黏膜下层 1 层且无淋巴管及血管侵犯,切缘无肿瘤残留,因此诊断为根治性切除。然而,该患者于 2009 年 5 月通过内镜超声引导下细针穿刺活检诊断为淋巴结转移。随后进行了远端胃切除术和 D2 淋巴结清扫术,证实了源于原发胃癌的淋巴结转移。